赵永强;
ZHAO Yong-qiang;Department of Hematology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院血液内科

摘要(Abstract)：

在抗凝治疗中,临床医生常会遇到一些无法从各种抗凝指南或共识中直接获解的问题,包括传统抗凝药物和新型抗凝药物的适用范围、不同抗凝阶段和特殊情况下的抗凝药物选择、抗凝疗程的确定和并发症的防治,需要医生根据所学知识和临床经验,并通过查阅文献给出个体化的解决方案。本文针对上述问题提出几点见解。
During the clinical practice of anticoagulation therapy,some puzzles,including the choice between traditional anticoagulants and novel alternatives,options of anticoagulants in different phases of the therapy or under exceptional circumstances,the determination of anticoagulation course,and management of complications,cannot be solved by consulting guidelines or consensuses. The individual regimen should be worked out by physicians according to their knowledge and clinical experiences,or by reviewing the literature. Several opinions were given in this article,aiming to provide a further understanding of above questions.

关键词(KeyWords)： 抗凝治疗;传统抗凝药物;新型抗凝药物;并发症
anticoagulation therapy;traditional anticoagulants;novel anticoagulants;complication

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 赵永强;
ZHAO Yong-qiang;Department of Hematology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

参考文献(References)：

• [1]朱铁楠,赵永强.2012版易栓症诊断中国专家共识解读[J].临床血液学杂志,2013,26:156-157.
• [2]Kearon C,Akl EA,Comerota AJ,et al.Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141:e419S-e494S.
• [3]Kearon C,Akl EA,Ornelas J,et al.Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report[J].Chest,2016,149:315-352.
• [4]中华医学会心血管病学分会肺血管病学组.急性肺栓塞诊断与治疗中国专家共识(2015)[J].中华心血管病杂志,2016,44:197-211.
• [5]中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中华普通外科杂志,2017,32:807-812.
• [6]张之南,郝玉书,赵永强,等.血液病学[M].第2版.北京:人民卫生出版社,2011:1404-1437.
• [7]Nutescu EA,Burnett A,Fanikos J,et al.Pharmacology of anticoagulants used in the treatment of venous Thromboembolism[J].J Thromb Thrombolysis,2016,41:15-31.
• [8]Kitchens CS,Kessler CM,Konkle BA.Consultative Hemostasis and Thrombosis[M].3rd ed.Philadelphia USA:Elsevier,2013:477-495.
• [9]Raffini L.Anticoagulation with VADs and ECMO:walking the tightrope[J].Hematology Am Soc Hematol Educ Program,2017,2017:674-680.
• [10]Ageno W,Gallus AS,Wittkowsky A,et al.Oral anticoagulant therapy antithrombotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141:e44S-e88S.
• [11]杨惊,赵永强.静脉血栓栓塞症的抗凝疗程及其影响因素[J].国际输血及血液学杂志,2010,33:126-129.
• [12]赵永强.肝素诱导的血小板减少症诊断与治疗常见问题[J].中国实用内科杂志,2013,(5):366-368.
• [13]Witt DM,Clark NP,Kaatz S,et al.Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism[J].J Thromb Thrombolysis,2016,41:187-205.